INFLUENCES ON THE ADOPTION OF NEW PHARMACEUTICAL TECHNOLOGIES: THE EXAMPLE OF THE FENTANYL PATCH

REFERENCES

• Fuchs V. Essays in the Economics of Health and Medical Care. Columbia University Press, New York 1972
   Google Scholar
• Singer I. Drugmakers Exit the Comfort Zone. The State of Health Care in America, 2001. Montvale, NJ 2001, Business & Health
   Google Scholar
• Freudenheim M. Drug Spending Rises Rapidly at Pharmacies and by Mail. New York Times 2002, May 16
   PubMedGoogle Scholar
• Rosenbaum D.E. States Make Cuts and Increase Fees as Revenues Drop. New York Times 2002, May 16
   PubMedGoogle Scholar
• Rogers E.M. Diffusion of Innovations. 3rd Edn., The Free Press, London 1983
   Google Scholar
• Bass F.M. A New Product Growth Model for Consumer Durables. Management Science 1969; 15(5)215–27
   Web of Science ®Google Scholar
• Williams J.R., Hensel P.J. Changes in Physicians' Sources of Pharmaceutical Information: a Review and Analysis. J. Health Care Mark. 1991; 11(3)46–60
   PubMedGoogle Scholar
• Avorn J., Chen M., Hartley R. Scientific Versus Commercial Sources of Influence on the Prescribing Behavior of Physicians. Am. J. Med. 1982; 73(1)4–8
   PubMed Web of Science ®Google Scholar
• Martinez B. Medco Finds Ties Bind. Wall Street Journal 2002, May 15
   Google Scholar
• Bennett J. HMOs are Driven to Tiers. Wall Street Journal 2002, June 6
   Google Scholar
• Rosenthal M., Berndt E., Donohue J. et al. Promotion of Prescription Drugs to Consumers. New Engl. J. Med. 2002; 346: 498–505
   PubMed Web of Science ®Google Scholar
• Hensley S. How Generics can Cut Your Drug Bills. Wall Street Journal 2002, June 6
   PubMedGoogle Scholar
• NCPA:
   Google Scholar
• Visawanathan H., Salmon J.W. Accrediting Organizations and Quality Improvement. American Journal of Managed Care 2000; 6: 1117–30
   PubMed Web of Science ®Google Scholar
• Salmon J. The professional and Corporate Context. Contested Ground: Public Purpose and Private Interest in the Regulation of Prescription Drugs, P. Davis. Oxford University Press, New York & London 1996
   Google Scholar
• Langley P. The Role of Pharmacoeconomics Guidelines for Formulary Approval: the Australian Experience. Clinical Therapeutics 1993; 15: 1154–76
   PubMed Web of Science ®Google Scholar
• Detsky A.S. Guidelines for Economic Analysis of Pharmaceutical Products: a Draft Document for Ontario and Canada. Pharmacoeconomics 1993; 3(5)354–61
   PubMedGoogle Scholar
• Glennie J.L., Torrance G.W., Baladi J.F. et al. The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals. Pharmacoeconomics 1999; 15(5)459–68
   PubMed Web of Science ®Google Scholar
• Sullivan S., Lyles A., Luce B. et al. AMCP Guidance for Submission of Clinical and Economic Evaluation Data to Support Formulary Listing in U.S. Health Plans and Pharmacy Benefits Management Organizations. J. Manag. Care Pharm. 2001; 7(4)272–82
   Google Scholar
• Data J.L., Willke R.J., Barnes J.R. et al. Re-engineering Drug Development: Integrating Pharmacoeconomic Research into the Drug Development Process. Psychopharmacol. Bull. 1995; 31(1)67–73
   PubMed Web of Science ®Google Scholar
• Johnson J., Bootman J. Pharmacoeconomic Analysis in Formulary Decisions: an International Perspective. Am. J. Hosp. Pharm. 1994; 51: 2593–8
   PubMedGoogle Scholar
• Princeton Survey Research Associates: Vital decisions: how Internet users decide what information to trust when they or their loved ones are sick, Pew Internet & American Life Project, 2002. http://www.pewinternet.org/reports/pdfs/PIP Vital Decisions May 20; Accessed June 10, 2002
   Google Scholar
• Borzo G. Consumer Drug Ads Booming: FDA Reviews Restrictions. American Medical News 1997; 1: 37, Feb 10
   Google Scholar
• Lambert B.L., Salmon J.W., Stubbings J. et al. Factors Associated with Antibiotic Prescribing in a Managed Care Setting: an Exploratory Investigation. Soc. Sci. Med. 1997; 45(12)1767–79
   PubMed Web of Science ®Google Scholar
• Lin S., Crawford S., Salmon J. Internal and External Influences on the Adoption of the Fentanyl Patch. J. Pharm. Mark Manage 2002, In press
   Google Scholar
• Sultan F., Farley J.U., Lehmann D.R. A Meta-analysis of Applications of Diffusion Models. Journal of Marketing Research 1990; 27: 70–7
   Web of Science ®Google Scholar
• Salmon, J. An Interview with Drug firm Representative, 2001. (Personal communication)
   Google Scholar
• Coleman J.S., Katz E., Menzel H. Medical Innovation: a Diffusion Study. Bobbs-Merrill Company, New York, NY 1966
   Google Scholar
• Kongstvedt P. Essentials of Managed Health Care. Aspen Publishers, Frederick, MD 1999
   Google Scholar
• Norton J.A., Bass F.M. A Diffusion Theory Model of Adoption and Substitution for Successive Generations of High Technology Products. Management Science 1987; 33: 1069–86
   Web of Science ®Google Scholar
• Salmon J. The Corporate Transformation of Health Care, Part II: Perspectives and Implication. Baywood Publishing Company, Amityville, NY 1994
   Google Scholar
• Relman A.S. Assessment and Accountability: the Third Revolution in Medical Care. N. Engl. J. Med. 1988; 319(18)1220–2
   PubMed Web of Science ®Google Scholar
• Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press: Washington, DC, Committee on Quality Health Care in America, Institute of Medicine, 2001.
   Google Scholar
• Kohn L.T., Corrigan J.M., Donaldson M.S. To err is Human: Building a Safer Health System. Committee on Quality of Health Care in America, Institute of Medicine. National Academy Press, Washington, DC 2000
   Google Scholar
• Eddy D., Evidence-based Medicine: A Practical Interpretation. In Academy of Managed Care Pharmacy 14th Annual Meeting, Salt Lake City, UT, 2002.
   Google Scholar
• Siu A.L., Sonnenberg F.A., Manning W.G. et al. Inappropriate Use of Hospitals in a Randomized Trial of Health Insurance Plans. N. Engl. J. Med. 1986; 315(20)1259–66
   PubMed Web of Science ®Google Scholar
• Wennberg J., Gittelsohn A. Variations in Medical Care Among Small Areas. Sci. Am. 1982; 246(4)120–34
   PubMed Web of Science ®Google Scholar
• Cleeland C.S., Janjan N.A., Scott C.B. et al. Cancer Pain Management by Radiotherapists: a Survey of Radiation Therapy Oncology Group Physicians. Int. J. Radiat. Oncol. Biol. Phys. 2000; 47(1)203–8
   PubMed Web of Science ®Google Scholar
• Thompson A.R., Savidge M.A., Fulper-Smith M. et al. Testing a Multimedia Module in Cancer Pain Management. J. Cancer Educ. 1999; 14(3)161–3
   PubMedGoogle Scholar
• Von Roenn J.H., Cleeland C.S., Gonin R. et al. Physician Attitudes and Practice in Cancer Pain Management. A Survey from the Eastern Cooperative Oncology Group. Ann. Intern. Med. 1993; 119(2)121–6
   PubMed Web of Science ®Google Scholar
• Clark H.W. Policy and Medical-legal Issues in the Prescribing of Controlled Substances. J. Psychoactive Drugs 1991; 23(4)321–8
   PubMed Web of Science ®Google Scholar